Terms: = Ovarian cancer AND KMT2D, ENSG00000167548, 8085, MLL2
18 results:
1. Integrated Analysis of ovarian Juvenile Granulosa Cell Tumors Reveals Distinct Epigenetic Signatures and Recurrent TERT Rearrangements.
Vougiouklakis T; Zhu K; Vasudevaraja V; Serrano J; Shen G; Linn RL; Feng X; Chiang S; Barroeta JE; Thomas KM; Schwartz LE; Shukla PS; Malpica A; Oliva E; Cotzia P; DeLair DF; Snuderl M; Jour G
Clin Cancer Res; 2022 Apr; 28(8):1724-1733. PubMed ID: 35031544
[TBL] [Abstract] [Full Text] [Related]
2. Histone Methyltransferase kmt2d Regulates H3K4 Methylation and is Involved in the Pathogenesis of ovarian cancer.
Li M; Shi M; Xu Y; Qiu J; Lv Q
Cell Transplant; 2021; 30():9636897211027521. PubMed ID: 34705580
[TBL] [Abstract] [Full Text] [Related]
3. Survival and Surgical Approach among Women with Advanced ovarian cancer Treated with Neoadjuvant Chemotherapy.
Persenaire C; Pyrzak A; Barber EL
J Minim Invasive Gynecol; 2022 Mar; 29(3):375-384. PubMed ID: 34648931
[TBL] [Abstract] [Full Text] [Related]
4. Adult-type granulosa cell tumor of the ovary: a FOXL2-centric disease.
Pilsworth JA; Cochrane DR; Neilson SJ; Moussavi BH; Lai D; Munzur AD; Senz J; Wang YK; Zareian S; Bashashati A; Wong A; Keul J; Staebler A; van Meurs HS; Horlings HM; Kommoss S; Kommoss F; Oliva E; Färkkilä AE; Gilks B; Huntsman DG
J Pathol Clin Res; 2021 May; 7(3):243-252. PubMed ID: 33428330
[TBL] [Abstract] [Full Text] [Related]
5. Microscopic extraovarian sex cord proliferation: report of a case with bilateral Fallopian tube involvement and a comprehensive molecular analysis.
Dundr P; Věcková Z; Tichá I; Hojný J; Němejcová K; Bártů M
Pol J Pathol; 2020; 71(2):175-180. PubMed ID: 32729308
[TBL] [Abstract] [Full Text] [Related]
6. An integrated molecular profile of endometrioid ovarian cancer.
Pierson WE; Peters PN; Chang MT; Chen LM; Quigley DA; Ashworth A; Chapman JS
Gynecol Oncol; 2020 Apr; 157(1):55-61. PubMed ID: 32139151
[TBL] [Abstract] [Full Text] [Related]
7. kmt2d/mll2 inactivation is associated with recurrence in adult-type granulosa cell tumors of the ovary.
Hillman RT; Celestino J; Terranova C; Beird HC; Gumbs C; Little L; Nguyen T; Thornton R; Tippen S; Zhang J; Lu KH; Gershenson DM; Rai K; Broaddus RR; Futreal PA
Nat Commun; 2018 Jun; 9(1):2496. PubMed ID: 29950560
[TBL] [Abstract] [Full Text] [Related]
8. Chromatin remodelling and DNA repair genes are frequently mutated in endometrioid endometrial carcinoma.
García-Sanz P; Triviño JC; Mota A; Pérez López M; Colás E; Rojo-Sebastián A; García Á; Gatius S; Ruiz M; Prat J; López-López R; Abal M; Gil-Moreno A; Reventós J; Matias-Guiu X; Moreno-Bueno G
Int J Cancer; 2017 Apr; 140(7):1551-1563. PubMed ID: 27997699
[TBL] [Abstract] [Full Text] [Related]
9. Clinical and genetic determinants of ovarian metastases from colorectal cancer.
Ganesh K; Shah RH; Vakiani E; Nash GM; Skottowe HP; Yaeger R; Cercek A; Lincoln A; Tran C; Segal NH; Reidy DL; Varghese A; Epstein AS; Sonoda Y; Chi D; Guillem J; Temple L; Paty P; Hechtman J; Shia J; Weiser M; Aguilar JG; Kemeny N; Berger MF; Saltz L; Stadler ZK
Cancer; 2017 Apr; 123(7):1134-1143. PubMed ID: 27875625
[TBL] [Abstract] [Full Text] [Related]
10. Long non-coding RNA profiling links subgroup classification of endometrioid endometrial carcinomas with trithorax and polycomb complex aberrations.
Jiang Y; Malouf GG; Zhang J; Zheng X; Chen Y; Thompson EJ; Weinstein JN; Yuan Y; Spano JP; Broaddus R; Tannir NM; Khayat D; Lu KH; Su X
Oncotarget; 2015 Nov; 6(37):39865-76. PubMed ID: 26431491
[TBL] [Abstract] [Full Text] [Related]
11. Exercise lowers estrogen and progesterone levels in premenopausal women at high risk of breast cancer.
Kossman DA; Williams NI; Domchek SM; Kurzer MS; Stopfer JE; Schmitz KH
J Appl Physiol (1985); 2011 Dec; 111(6):1687-93. PubMed ID: 21903887
[TBL] [Abstract] [Full Text] [Related]
12. BRCA1 gene mutations may explain more than 80% of excess number of ovarian cancer cases after breast cancer - a population based study from the Western Sweden Health Care region.
Einbeigi Z; Enerbäck C; Wallgren A; Nordling M; Karlsson P
Acta Oncol; 2010 Apr; 49(3):361-7. PubMed ID: 20151938
[TBL] [Abstract] [Full Text] [Related]
13. High-throughput resequencing in the diagnosis of BRCA1/2 mutations using oligonucleotide resequencing microarrays.
Schroeder C; Stutzmann F; Weber BH; Riess O; Bonin M
Breast Cancer Res Treat; 2010 Jul; 122(1):287-97. PubMed ID: 19941162
[TBL] [Abstract] [Full Text] [Related]
14. [Results of fertility preserving operations in malignant ovarian tumors].
Kleine W
Zentralbl Gynakol; 1996; 118(6):317-21. PubMed ID: 8768006
[TBL] [Abstract] [Full Text] [Related]
15. Validity of colour and pulsed Doppler US and tumour marker CA 125 in differentiation between benign and malignant ovarian masses.
Antonić J; Rakar S
Eur J Gynaecol Oncol; 1996; 17(1):29-35. PubMed ID: 8750512
[TBL] [Abstract] [Full Text] [Related]
16. Colour and pulsed Doppler US and tumour marker CA 125 in differentiation between benign and malignant ovarian masses.
Antonić J; Rakar S
Anticancer Res; 1995; 15(4):1527-32. PubMed ID: 7654041
[TBL] [Abstract] [Full Text] [Related]
17. Application of cancer procoagulant as an early detection tumor marker.
Kozwich DL; Kramer LC; Mielicki WP; Fotopoulos SS; Gordon SG
Cancer; 1994 Aug; 74(4):1367-76. PubMed ID: 8055461
[TBL] [Abstract] [Full Text] [Related]
18. Growth inhibition of ovarian cancer cells induced by antisense IL-6 oligonucleotides.
Watson JM; Berek JS; Martínez-Maza O
Gynecol Oncol; 1993 Apr; 49(1):8-15. PubMed ID: 8482564
[TBL] [Abstract] [Full Text] [Related]
